New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 28, 2013
09:26 EDTAFAM, PFE, BIIB, DNDN, GTIV, ABFS, ACI, ACN, LHCG, AMED, SNY, MCP, BBRYOn The Fly: Pre-market Movers
HIGHER: Dendreon (DNDN), up 9.8% after getting positive EU opinion for Provenge drug... Arkansas Best (ABFS), up 10% after ABF Freight System employees represented by Teamsters ratify five-year national labor agreement... Molycorp (MCP), up 7.8% after SEC completes investigation with no enforcement action recommended... Arch Coal (ACI), up 8.9% after announcing will sell non-core Utah operations to Bowie Resources for $435M... Biogen (BIIB), up 5.8% after the European Medicines Agency granted Sanofi's multiple sclerosis drug Aubagio "new active substance" status. Sanofi, which also received a positive CHMP opinion for Lemtrada, up 1.5%... Pfizer (PFE), up 1% after boosting share buyback program by $10B. DOWN AFTER EARNINGS: BlackBerry (BBRY), down 23%... Accenture (ACN), down 9%... Nike (NKE), down 0.8%. ALSO LOWER: Home health agencies, including Amedisys (AMED), down 21%, Gentiva Health (GTIV), down 16%, Almost Family (AFAM), down 13%, and LHC Group (LHCG), down 12%, after the Centers for Medicare & Medicaid Services proposed 2014 reimbursement cuts.
News For BBRY;ACN;DNDN;MCP;ACI;BIIB;SNY;ABFS;PFE;AMED;GTIV;AFAM;LHCG From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | 5 | all recent news | >>
June 23, 2015
09:36 EDTBBRYActive equity options trading on open
Subscribe for More Information
09:14 EDTBBRYOn The Fly: Pre-market Movers
Subscribe for More Information
08:56 EDTBBRYBlackBerry CEO: Company well positioned to grow security business
Subscribe for More Information
07:55 EDTBIIBBiogen's Tysabri in SPMS a $1B-$2B opportunity, says Morgan Stanley
Subscribe for More Information
07:33 EDTBBRYBlackBerry, Cisco sign broad patent cross-licensing agreement
Subscribe for More Information
07:25 EDTPFEPiper Jaffray to hold a summit
2015 Piper Jaffray Heartland Summit is being held in Minneapolis on June 23-24.
07:13 EDTBBRYBlackBerry up 7.6% after reporting Q1 results
07:06 EDTBBRYBlackBerry CEO says taking steps to make handset business profitable
Subscribe for More Information
07:05 EDTBBRYBlackBerry continues to anticipate positive free cash flow in FY16
Subscribe for More Information
07:05 EDTBBRYBlackBerry recognized hardware revenue on 1.1M smartphones
Subscribe for More Information
07:02 EDTBBRYBlackBerry reports Q1 EPS (5c), consensus (3c)
Subscribe for More Information
05:56 EDTBBRYEarnings Watch: Analyst says BlackBerry's FY16 targets looking 'unttainable'
Subscribe for More Information
June 22, 2015
19:56 EDTACIUtilities sector dips after EPA warns of 'significant risks' from climate change
Subscribe for More Information
15:46 EDTBBRYBlackberry June weekly 9 straddle priced for 7.6% movement into Q1
Subscribe for More Information
15:00 EDTBBRYNotable companies reporting before tomorrow's open
Subscribe for More Information
13:00 EDTBBRYBlackberry June weekly volatility elevated into Q1 and outlook
Blackberry June weekly call option implied volatility is at 88, July is at 49, August is at 44; compared to its 52-week range of 34 to 75, suggesting large near term price movement into the expected release of Q1 results on June 23.
11:21 EDTBBRYStocks with call strike movement; TWTR BBRY
Subscribe for More Information
08:52 EDTPFEPortola, Bristol-Myers, and Pfizer announce results from Phase 3 ANNEXA study
Subscribe for More Information
07:01 EDTPFEPfizer to acquire Nimenrix, Mencevax from GlaxoSmithKline for $130M
Pfizer (PFE) announced that it has entered into an agreement with GlaxoSmithKline (GSK) to acquire its quadrivalent meningitis ACWY vaccines, Nimenrix and Mencevax, for a total consideration of approximately $130M. This transaction will add two high-quality and complementary vaccines to Pfizer’s portfolio, allowing the company to reach a broader global population. Nimenrix is a single dose meningococcal ACWY-TT conjugated vaccine designed to protect against Neisseria meningitidis, an uncommon but highly contagious disease that can lead to disability and death. Mencevax is a single-dose meningococcal ACWY unconjugated polysaccharide vaccine used to control outbreaks of meningococcal infection and for travelers to countries where the disease is endemic or highly epidemic. Pfizer does not expect this transaction to have any significant impact on its 2015 financial performance. The transaction is subject to customary closing conditions as well as regulatory approvals in several markets, and is expected to occur in the second half of 2015. Pfizer’s legal advisors for the transaction were Ropes & Gray and Clifford Chance.
05:53 EDTMCPStocks with implied volatility movement; MCP NCR
Stocks with implied volatility movement; Molycorp (MCP) 536, NCR Corp. (NCR) 41 according to iVolatility.
1 | 2 | 3 | 4 | 5 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use